Karsanbhai Surendralal Lanca 4
4 · Merck & Co., Inc. · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
Merck (MRK) Director Surendralal Lanca Receives Award
What Happened
- Director Surendralal Lanca received a grant (listed as a derivative acquisition) of 1,853.1 shares/units on 2026-05-29 at a per-unit value of $118.72, for a total reported value of $220,000. This was an award/grant (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-05-29; filing date: 2026-06-02 (appears timely under the Form 4 two-business-day rule).
- Instrument: Derivative award (phantom stock units), 1,853.1 units @ $118.72 = $220,000 (reported as an acquisition, code A).
- Settlement: Footnote F2 indicates the phantom stock units will be settled 100% in cash upon the reporting person's termination of service, under the Plan for Deferred Payment of Directors' Compensation.
- Other footnotes: F1 indicates a 1-for-1 ratio; F3 notes holdings may include shares acquired via dividend reinvestment.
- Shares owned after the transaction: not specified in the summary provided.
Context
- This was an award of deferred/phantom stock units (a compensation grant), not a buy or sell of common stock; such awards are routine director compensation and are settled in cash per the plan rather than creating immediate common-stock ownership.
Insider Transaction Report
Form 4
Karsanbhai Surendralal Lanca
Director
Transactions
- Award
Phantom Stock
[F1][F2][F3]2026-05-29$118.72/sh+1,853.1$220,000→ 5,392.343 total→ Common Stock (1,853.1 underlying)
Holdings
- 1
Common Stock
Footnotes (3)
- [F1]1-for-1
- [F2]Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
- [F3]Holdings include shares acquired in dividend reinvestment transactions.
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Surendralal L. Karsanbhai|2026-06-02